[Effectiveness of adjuvant endocrine therapy for postoperative breast cancer patients].
Department of Breast and Endocrine Surgery, Okayama University Hospital of Medicine and Dentistry.
Hiroyoshi
H
Doihara
Yutaka
Y
Ogasawara
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D047072:Aromatase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008408:Mastectomy; D008593:Menopause; D013629:Tamoxifen / Q000008:administration & dosage*
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D013629:Tamoxifen